The significant downregulation of ELANE observed in the tumor samples assessed was probably related to the inhibited tumor immunity in the BC patients, which is in accordance with a previous study [89], and with our analysis of the DEGs between the high-risk and low-risk groups. This evidence concerns the gene ELANE and neoplasm.